Home > Boards > US Listed > Biotechs > Sesen Bio (SESN)

maybe going back to .25??

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Boom77 Member Profile
 
Followed By 0
Posts 15
Boards Moderated 1
Alias Born 11/21/17
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 1/19/2021 8:01:12 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/13/2021 8:02:49 AM
Sesen Bio & Qilu Pharmaceutical Announce IND Application for Vicineum™ Accepted for Review by the National Medical Products... Business Wire - 1/13/2021 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/11/2021 8:03:16 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/23/2020 11:48:09 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/21/2020 8:02:20 AM
Sesen Bio Submits Completed Biologics License Application to the FDA for Vicineum™ and Has Requested Priority Review Business Wire - 12/21/2020 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/18/2020 8:04:42 AM
Sesen Bio Announces Positive Cost-Effectiveness Profile for Vicineum™ Based on the Final Evidence Report Issued by the Inst... Business Wire - 12/18/2020 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/15/2020 8:00:54 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/9/2020 8:01:35 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/7/2020 8:04:42 AM
Sesen Bio Announces Commercial Manufacturing and Global Supply Partnership with Qilu Pharmaceutical Business Wire - 12/7/2020 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/3/2020 8:11:30 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/1/2020 8:05:54 AM
Sesen Bio Announces Partnership with Hikma Pharmaceuticals for the Commercialization of Vicineum™ in the Middle East & Nort... Business Wire - 12/1/2020 8:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/9/2020 4:08:29 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/9/2020 7:34:46 AM
Sesen Bio Reports Third Quarter 2020 Financial Results & Positive Progress Towards Completing the BLA Submission for Vicineum... Business Wire - 11/9/2020 7:30:00 AM
Sesen Bio to Host Conference Call to Review Third Quarter Financial Results & Provide an Update on Positive Progress Towards ... Business Wire - 11/2/2020 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/30/2020 4:07:51 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 10/30/2020 4:03:17 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/26/2020 8:03:12 AM
Sesen Bio Announces Successful Pre-Submission Meeting with the European Medicines Agency for Vicineum™ Business Wire - 10/26/2020 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/19/2020 8:03:14 AM
Boom77   Tuesday, 11/21/17 03:16:49 PM
Re: None
Post # of 6092 
maybe going back to .25??

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences